ViennaLab Diagnostics focuses on developing user-friendly in vitro diagnostic assays that detect genetic variants linked to various health conditions, including genetic disorders, cancer, pharmacogenetics, and the human microbiome. Their product offerings include a diverse range of assays categorized under cancer, genetic predispositions, and microbiome analysis, utilizing advanced technologies such as RealFast Assays, StripAssays, and Next Generation Sequencing (NGS). These assays are designed to meet specific diagnostic needs, providing healthcare professionals with tools to better understand hereditary diseases and tailor personalized medicine approaches.

The NGS technology employed by ViennaLab utilizes both amplicon-based and hybridization capture techniques for target enrichment, allowing for precise and efficient analysis of genetic material. This technology has significantly advanced the understanding of hereditary diseases and cancer, as well as improved the classification of microbial species. ViennaLab also emphasizes the importance of comprehensive support for their NGS products, offering assistance with experimental library preparation and bioinformatics analysis to ensure optimal utilization of their diagnostic tools.

Austria

ViennaLab Diagnostics is a medical diagnostics company that develops and manufactures user-friendly in-vitro diagnostic products for human genetic testing, specializing in assays for detecting genetic variants associated with genetic disorders and pharmacogenetics.

ViennaLab Diagnostics

Company Details